Kidney Commute

kidneycommute

The Kidney Commute podcast seeks to enhance the work of the interprofessional kidney care team by providing connection through education and CE credits for eligible listeners, while the Pitstop sub-series is a non-accredited exploration of what drives innovation in the nephrology field. Two opportunities to learn, one opportunity to earn.

  1. 25 juin

    Pitstop: Beyond Binders: Evolving the Hyperphosphatemia Playbook

    Hyperphosphatemia affects a significant proportion of patients receiving dialysis and remains a complex challenge for kidney care teams. In this episode of Kidney Commute Pit Stop, Anna Gaddy welcomes nephrologist Jessica Kendrick, clinical pharmacist Kimberly Holdener, and renal nutrition expert David St-Jules to explore what phosphorus management looks like in 2026. The panel discusses the evolution of the "renal diet," emerging evidence on phosphorus bioavailability, the impact of food additives and processing, and how individualized nutrition counseling can improve patient outcomes. They also review traditional phosphorus binders, challenges with adherence and pill burden, and the emerging role of tenapanor, a first-in-class phosphorus blocker. Listeners will gain practical insights for helping patients navigate phosphorus management while maintaining a balanced, patient-centered approach to nutrition and quality of life. This episode is supported by Ardelyx. Please click here, to view a clinical bulletin update on managing hyperphosphatemia in patients on dialysis. Upon completion of the podcast, please complete this short survey: https://nkf.jotform.com/261544521599868

    38 min

  2. 16 juin

    Pitstop: Plant-based Enteral Formulas for People with CKD

    Disclosure: The content and opinions of the podcast are those of the guests; these are not claims or recommendations for Kate Farms products. Plant-based nutrition has emerged as an important component of kidney care, but questions remain about how plant-based enteral formulas can best support people living with chronic kidney disease (CKD). In this episode of Kidney Commute: Pit Stop, host Dr. Raphy Rosen is joined by Brandon Kistler, PhD, RD, and Rachel Wontor, MS, RDN, CD, CNSC, to explore the growing role of plant-based enteral nutrition in clinical practice. The discussion examines the key features of plant-based formulas, including standard, renal-specific, peptide, and specialty options, and reviews how these products compare with traditional formulas in meeting nutritional needs. The panel also discusses when renal formulas may or may not be necessary, current evidence related to effectiveness and patient acceptance, insurance coverage considerations, and practical approaches for implementing plant-based enteral nutrition in healthcare settings. Clinicians will gain actionable insights to help support individualized nutrition care for people with CKD. After listening to the podcast, please take a moment to complete the quick survey at https://nkf.jotform.com/261534175734863

    32 min

  3. 29 mai

    Hidden Phosphorus: Understanding Phosphate Additives in Food

    Phosphate additives are commonly used in processed and convenience foods, yet many patients and healthcare professionals remain unaware of how significantly they contribute to phosphorus burden in chronic kidney disease (CKD). Elevated phosphorus levels can negatively impact bone, cardiovascular, and overall kidney health, making phosphorus management an important aspect of kidney care. In this episode of Kidney Commute, an interprofessional panel featuring a nephrologist, dietitian, policy expert, and patient advocate discusses the clinical impact of phosphate additives, the differences between naturally occurring phosphorus and additive-based phosphorus, and the practical challenges patients face when trying to identify hidden phosphorus sources in foods and medications. The discussion also explores socioeconomic barriers, food labeling limitations, and ongoing policy and advocacy efforts aimed at improving phosphorus transparency and patient education. Listeners will gain practical strategies and insights to better support phosphorus management in clinical practice and daily life.

    40 min

  4. 8 mai

    Pitstop: Global Guidelines: U.S. Insights from KDOQI - Optimizing Management of IgAN and IgAV

    IgA nephropathy and IgA vasculitis remain complex and evolving areas in nephrology care. In this episode, experts discuss key insights from the KDIGO guidelines and KDOQI commentary published in AJKD, focusing on updated approaches to risk stratification, disease progression, and treatment decision making. The conversation highlights the role of supportive care, immunosuppressive therapy considerations, and emerging therapeutic options, while addressing variability in clinical practice and patient management challenges. This episode provides practical, evidence based perspectives to help clinicians navigate the nuances of IgAN and IgAV care and apply guideline recommendations in real world settings. Please view the AJKD article here.

    21 min

  5. 8 mai

    Pitstop: Global Guidelines: U.S. Insights from KDOQI - Improving Anemia Management in CKD

    Anemia in chronic kidney disease remains common, complex, and rapidly evolving. In this episode, experts discuss key updates from the 2026 KDIGO Clinical Practice Guidelines and AJKD commentary, including a stronger focus on identifying and treating iron deficiency and refining treatment strategies. The conversation explores the clinical impact of anemia on cardiovascular risk and quality of life, reviews evidence supporting proactive IV iron use, and examines emerging therapies such as HIF stabilizers. The panel also addresses real world challenges in managing anemia, particularly in non dialysis CKD populations, where access, adherence, and care coordination play a critical role. This episode provides practical insights to support individualized, evidence based anemia care. Please click here to access the commentary.

    39 min

  6. 28 avr.

    Pitstop: Congress Cares about Kidneys: Unpacking the recent congressional hearing about kidney health

    Kidney care rarely takes center stage in Congress, but a recent hearing is bringing renewed attention to prevention, innovation, and patient access. In this episode, host Raphy Rosen is joined by Dr. Suzanne Watnick, who testified as a witness at the March 18 Ways and Means Health Subcommittee hearing, along with Dr. Dan Weiner. Together, they unpack key themes across CKD, dialysis, and transplantation, and explore what emerging legislative efforts could mean for patients and providers. Tune in for an inside look at how kidney care is shaping national health policy.

    34 min

  7. 31 mars

    Pitstop: Global Guidelines: U.S. Insights from KDOQI: Optimizing ADPKD Evaluation and Treatment

    In this episode of Kidney Commute: Pitstop, we explore key insights from the KDIGO Commentary on the 2025 KDOQI Clinical Practice Guideline for autosomal dominant polycystic kidney disease (ADPKD). Host Anna Gaddy is joined by Dr. Neera Dahl and Dr. Terry Watnick to discuss how the updated recommendations differ from prior guidance and what they mean for real world practice in the United States. The conversation highlights advances in genetic testing, practical considerations for implementing tolvaptan therapy, and emerging therapies on the horizon. Tune in for actionable takeaways to support clinical decision making and improve care for patients with ADPKD.   Access the commentary here: https://www.ajkd.org/article/S0272-6386(26)00003-X/fulltext

    30 min

  8. 19 mars

    Pitstop: NephMadness 2026: Cerebronephrology Region: Exploring the Intersection Between Kidney Disease and Brain Health

    Hosted by Dr. Sam Kant, this Kidney Commute: Pit Stop episode explores the Cerebronephrology region of NephMadness 2026 and the emerging concept of the brain–kidney axis. Drs. David Drew and Colton Jensen examine how chronic kidney disease and ESKD with dialysis contribute to cognitive impairment—an underrecognized complication affecting a large proportion of patients. From early microvascular injury, albuminuria, and hypertension in CKD to cerebral hypoperfusion, ischemia, and structural brain changes during dialysis, this discussion highlights the bidirectional relationship between kidney and brain health. Join us as we unpack where brain injury begins and what this means for earlier recognition and improved patient care. For more information on the Cerebronephrology Region of NephMadness please go to: https://ajkdblog.org/2026/03/01/nephmadness-2026-cerebronephrology-region/

    26 min
Tout afficher (56)

Notes et avis

4,9
sur 5
28 notes

À propos

The Kidney Commute podcast seeks to enhance the work of the interprofessional kidney care team by providing connection through education and CE credits for eligible listeners, while the Pitstop sub-series is a non-accredited exploration of what drives innovation in the nephrology field. Two opportunities to learn, one opportunity to earn.

Informations

  • Création
    kidneycommute
  • Années d’activité
    2022 - 2026
  • Épisodes
    56
  • Classification
    Tous publics
  • Copyright
    © Copyright 2021 All rights reserved.
  • Site web de l’émission
    Kidney Commute

Vous aimeriez peut‑être aussi